BALAMINES vs KRONOX: Stock Comparison

Balaji Amines Limited vs Kronox Lab Sciences Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Balaji Amines Limited is the larger company by market capitalisation. Balaji Amines Limited shows a higher dividend yield and faster revenue growth, while Kronox Lab Sciences Limited shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Balaji Amines Limited and Kronox Lab Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BALAMINES is more favourable on 7 of 13 scored metrics and KRONOX on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BALAMINES is the larger company
₹7,014 Cr vs ₹569 Cr
P/E Ratio
KRONOX has a lower P/E
20.7x vs 43.07x
P/B Ratio
BALAMINES has a lower P/B
3.69x vs 4.93x
EPS
BALAMINES has higher earnings per share
₹51.89 vs ₹7.45
Dividend Yield
BALAMINES has a higher dividend yield
0.46% vs 0.33%
Revenue Growth (TTM YoY)
BALAMINES has faster revenue growth
11.9% vs 0%
EPS Growth (TTM YoY)
BALAMINES has faster EPS growth
61.7% vs 26.7%
Qtr Sales Growth
BALAMINES has stronger quarterly sales growth
11.9% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBALAMINESKRONOX
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricBALAMINESKRONOX
Live Price₹2,174.5₹154.39
Day Change-7.44%1.3%
Volume2.91 L86,661
52-Week High₹2,443.6₹187.91
52-Week Low₹968.1₹96
Distance from 52W High-11.01%-17.84%

Valuation

MetricBALAMINESKRONOX
Market Cap₹7,014 Cr₹569 Cr
P/E Ratio43.07x20.7x
P/B Ratio3.69x4.93x
EPS₹51.89₹7.45
Book Value₹610₹31.64
Dividend Yield0.46%0.33%

Growth

MetricBALAMINESKRONOX
Revenue Growth (TTM YoY)11.9%0%
EPS Growth (TTM YoY)61.7%26.7%
Qtr Sales Growth11.9%0%
Qtr Profit Growth57.8%26.6%

Profitability & Leverage

MetricBALAMINESKRONOX
ROE8.74%26.8%
ROCE11%36%
Net Margin11.73%27.21%
Operating Margin18.7%33.9%
Debt to Equity0.07x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBALAMINESKRONOX
Promoter Holding54.56% 0.03 pp74.21%
FII Holding3.17% 0.19 pp0.04% 0.04 pp
DII Holding1.59% 0.13 pp2.07% 0.02 pp
Public Holding40.69% 0.28 pp23.67% 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Balaji Amines Limited and Kronox Lab Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.